Pulmo BioTech Inc. Announces Paper to be Presented at... (rs. About PulmoScience Inc. ...)

Pulmo BioTech Inc. Announces Paper to be Presented at Symposium

Date:5/4/2009

rs.

About PulmoScience Inc.

PulmoScience Inc. was established in 2006, and is currently developing a non-invasive Molecular Imaging technique for the diagnosis of Pulmonary Embolism, Pulmonary Hypertension and Lung Inflammatory diseases under the trade name PulmoBind.

PulmoScience was conceived within the Montreal Heart Institute "MHI" (a world renowned hospital and educational facility). Jointly owned by MHI subsidiary Innovacor as the technical and operational partner, Dr. Jocelyn Dupuis (the scientific director and originator of the PulmoBind Molecular Imaging technology), and by Pulmo BioTech Inc. as the funding partner, PulmoScience Inc. aims to develop this unique and exciting technology, to fund necessary trials, and to bring the products to market.

PulmoScience believes that the market for its product candidates is worth in excess of $500 million per annum and that, provided Regulatory Approval is achieved, the safety and efficacy of its products could allow it to dominate that market.

About PulmoBind

PulmoBind uses an intravenously delivered radionuclide tagged molecule which specifically bonds to the inner walls of the circulatory system in the lungs, and by the use of an external Gamma Camera allows an image of the integrity of the blood vessels throughout the lungs to be seen by a diagnostic clinician. PulmoScience is currently undertaking Regulatory Approval for Phase I Human Trials, and while subsequent results from additional tests might not corroborate the current results, PulmoScience believes that PulmoBind has the potential to dominate the market for the diagnosis of Pulmonary Embolism. In particular, this belief is driven by PulmoScience's expectations of the improved safety and efficacy that PulmoBind will offer when compared to the current incumbent nuclear medicine based technology for the diagnosis of Pulmonary Embolism. In addition,
'/>"/>

SOURCE Pulmo BioTech Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related biology technology :

1. FDA Approves SYMBICORT(R) for Chronic Obstructive Pulmonary Disease (COPD)
2. Nektar Announces Closing of Sale of Specific Pulmonary Delivery Assets to Novartis for $115 Million
3. Soliris(R) Reduced Measures of Thrombosis and Inflammation, and Decreased Indicators of Pulmonary Hypertension, in Studies of Patients with PNH
4. Nektar Sells Pulmonary Business to Novartis For $115 Million and Nektar Retains Key Pulmonary Programs Including Amikacin Inhale, Inhaled Vancomycin, and Ciprofloxacin Inhalation Powder
5. Pulmonary Hypertension Association Names Recipient of 2008 Award of Excellence in Pulmonary Arterial Hypertension (PAH) Care
6. Coalition for Pulmonary Fibrosis and American Thoracic Society Continue Research Partnership Through 2010
7. Pulmo BioTech Announces an Increase in its Stake in PulmoScience
8. Nektar Receives Patent Covering Pulmonary Targeted Antibiotics
9. Pulmo BioTech Announces Appointment of Chief Financial Officer
10. eResearchTechnology, Inc. and nSpire Health, Inc. Form Alliance to Deliver Integrated Cardiac Safety and Pulmonary Clinical Trial Services
11. CryoLife Announces Implant of First FDA-Cleared SynerGraft(R) Processed Human Pulmonary Heart Valve

Post Your Comments:

(Date:12/15/2009)... three Department of Energy (DOE) bio-energy research centers, has ... valuable intellectual property. , ... ... Surety, LLC , the leading provider of ... Joint BioEnergy Institute (JBEI), one of three Department of ...

(Date:12/15/2009)... SAN DIEGO, Dec. 15 Aethlon Medical, ... that Dr. Jeff Schorey and Dr. Wayne Comper ... of Exosome Sciences, Inc. (ESI). Both Dr. Schorey ... exosome field. ESI, a wholly owned subsidiary of ... discovery that the Hemopurifier®, a medical device being ...

(Date:12/15/2009)... BRIARCLIFF MANOR, N.Y., Dec. 15 The ... announced that the professional society is continuing to ... is being held in Arlington, VA, April 19-21, ... society is encouraging non-members to join the organization ... event. The submission deadline is 12 AM EST, ...

(Date:12/15/2009)... - 45 Patients Enrolled ... Cells to Restore Cardiac Function ,, ... company specialising,in cell-based therapies for the treatment of ... months ahead of schedule,enrolment in the first stage ... a,unique stem cell therapy for heart failure. Forty-five ...

Breaking Biology Technology:Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 2 Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 3 Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 4 Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 5 Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 2 Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 3 Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 4 Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 5 The International Society for Medical Publication Professionals Announces Call for Abstracts for Its 6th Annual Meeting 2 The International Society for Medical Publication Professionals Announces Call for Abstracts for Its 6th Annual Meeting 3 Cardio3 BioSciences Completes Patient Enrolment in First Stage of Pivotal Trial of C-Cure(R) in Heart Failure 2 Cardio3 BioSciences Completes Patient Enrolment in First Stage of Pivotal Trial of C-Cure(R) in Heart Failure 3

[0] Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property [0] Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board [0] The International Society for Medical Publication Professionals Announces Call for Abstracts for Its 6th Annual Meeting [0] Cardio3 BioSciences Completes Patient Enrolment in First Stage of Pivotal Trial of C-Cure(R) in Heart Failure

... Inc. (Nasdaq:, BLUD ), a global leader in ... announced that it expects to release its,fiscal second quarter ... regular trading hours, and then host a conference call ... review the results. Investors are invited to,participate in ...

... Enhance Precision Farming Technology Available to Industry and Pioneer Customers ... ... 29, 2008 -- DuPont business Pioneer Hi-Bred and MapShots ... , a privately owned agricultural data management company that develops and ...

... and PHILADELPHIA, Pennsylvania,December 29 Rosetta Genomics, ... molecular diagnostics, announced,today the introduction of its ... now commercially available through Rosetta Genomics CLIA-certified,lab ... To order the test, physicians may contact ...

Other Biology Technology:Immucor Schedules Second Quarter Earnings Release and Conference Call 2 DuPont Acquires Ag Data Management Business to Enhance Information Solutions for Growers 2 DuPont Acquires Ag Data Management Business to Enhance Information Solutions for Growers 3 Rosetta Genomics Announces Commercial Availability of Its Third MicroRNA-Based Diagnostic Test: miRview(TM) meso 2 Rosetta Genomics Announces Commercial Availability of Its Third MicroRNA-Based Diagnostic Test: miRview(TM) meso 3 Rosetta Genomics Announces Commercial Availability of Its Third MicroRNA-Based Diagnostic Test: miRview(TM) meso 4 Rosetta Genomics Announces Commercial Availability of Its Third MicroRNA-Based Diagnostic Test: miRview(TM) meso 5

Immucor Schedules Second Quarter Earnings Release and Conference Call DuPont Acquires Ag Data Management Business to Enhance Information Solutions for Growers Rosetta Genomics Announces Commercial Availability of Its Third MicroRNA-Based Diagnostic Test: miRview(TM) meso

(Date:12/15/2009)... Clinical Laboratory, San Diego, California, has been awarded ... (CAP), based on results of a recent onsite ... advised of this national recognition and congratulated for ... Biotech Inc. GenWay Clinical Laboratory is one of ... Laboratory Accreditation Program, begun in the early 1960s, ...

(Date:12/15/2009)... a team of Spanish and American researchers found the fossil ... Huelva. Now they have published, for the first time, the ... the death of the young cetacean, possibly a baleen whale ... discovery of the partial fossil remains of a whale from ... Sands sedimentary formation, but it is the first time that ...

(Date:12/15/2009)... mouse is a standard laboratory model organism, but ... techniques to analyze blood and blood-forming tissues in ... compact and easy-to-use laboratory resources from Cold Spring ... Mouse Hematology features step-by-step protocols for the ... bone marrow, and other hematopoietic tissues in the ...

[0] GenWay Clinical Laboratory receives accreditation from College of American Pathologists [0] Story of 4.5 million-year-old whale unveiled in Huelva [0] New source of classical techniques for blood-based studies in the laboratory mouse

... combination of extended wakefulness and low-dose alcohol has significant ... elevates the risk of getting into a vehicular accident, ... issue of the journal SLEEP. , The study, authored ... Breathing and Sleep in Heidelberg, Victoria, Australia, focused on ...

... population, farm income, and crop production in the ... and the environment are counterbalanced by surprising stability ... , The survey, published in the October ... such as improved crop varieties, irrigation, and fertilizer ...

... carbohydrates claims that eating so-called bad carbohydrates will make ... says, thats just nonsense. Eating sandwiches with white bread, ... or necessarily even lead to obesity, he said. , ... Journal of the American Dietetic Association, Gaesser analyzes peer-reviewed, ...

Other Biology News:Extended wakefulness, combined with alcohol, severely impairs driving performance 2 'Bad carbs' not the enemy, University of Virginia professor finds 2

Extended wakefulness, combined with alcohol, severely impairs driving performance Great Plains' historical stability vulnerable to future changes 'Bad carbs' not the enemy, University of Virginia professor finds

BI-1 Polyclonal Antibody Storage Temperature: -20C Shipping: gel pack Shelf-Life: 12 months...

...

Ras-related C3 botulinum toxin substrate 1...

Biology Products:

Rabbit Anti-BI-1 Polyclonal Antibody, Unconjugated from BioVision Capped Xef-1 RNA 0.05 ml from Ambion Human TIMP-1 ELISpot Kit from R&D Systems Chicken Anti-Ras-related C3 botulinum toxin substrate 1 Polyclonal Antibody, Unconjugated from GenWay Biotech, Inc.

Pulmo BioTech Inc. Announces Paper to be Presented at...(rs. About PulmoScience Inc. ...)